HCAT HEALTH CATALYST INC

Ownership history in Nepsis Inc.  ·  24 quarters on record

This page tracks every 13F SEC filing in which Nepsis Inc. reported a position in HEALTH CATALYST INC (HCAT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
4.06% (2024 Q3)
Avg. % of fund
2.78%
First filed
2019 Q3
Last filed
2025 Q4
Quarters held
24
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,915,794 +402,762 +26.6% 1.41% $4.6M $2.39
2025 Q3 REDUCED 1,513,032 -212,033 -12.3% 1.37% $4.3M $2.85
2025 Q2 REDUCED 1,725,065 -365,747 -17.5% 1.81% $6.5M $3.77
2025 Q1 ADDED 2,090,812 +1,994,555 +2072.1% 2.34% $9.5M $4.53
2024 Q4 REDUCED 96,257 -2,008,271 -95.4% 2.53% $10.1M $7.07
2024 Q3 ADDED 2,104,528 +851,448 +67.9% 4.06% $17.1M $8.14
2024 Q2 ADDED 1,253,080 +95,686 +8.3% 2.16% $8.0M $6.39
2024 Q1 ADDED 1,157,394 +65,462 +6.0% 2.36% $8.7M $7.53
2023 Q4 ADDED 1,091,932 +186,128 +20.5% 2.88% $10.1M $9.26
2023 Q3 ADDED 905,804 +63,065 +7.5% 2.81% $9.2M $10.12
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HCAT price (monthly, adj. close)
← Back to Nepsis Inc. Holdings